Accriva Diagnostics, Inc. Recalls
2 recalls on record in the United States
medical: 2
medical
Class II
2026-06-24
Accriva Diagnostics, Inc. recalls directCHECK ACT-LR whole blood quality control, level 2 Mod
Assayed Whole blood control contains labeling with incorrect performance range.
View recall details →
medical
Class II
2026-11-11
Accriva Diagnostics, Inc. recalls Hemochron Jr., Whole Blood Microcoagulation System, Activate
Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
View recall details →